Form 4: BioMarin Director Elizabeth Anderson Reports Stock Grant and Disposal
SEC Form 4 Filing
Director Elizabeth Anderson reported the acquisition of 6,650 shares of BioMarin Pharmaceutical Inc. stock through a grant and the disposal of an unspecified amount of shares.
Summary
- On May 20, 2025, Elizabeth M Anderson, a director of BioMarin Pharmaceutical Inc., reported a transaction involving the company's common stock.
- Anderson acquired 6,650 shares of common stock through a grant.
- Anderson disposed of an unspecified amount of shares.
- Following the reported transaction, Anderson beneficially owns 34,450 shares of BioMarin common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.
Stakeholder Impact
- The transaction may have a minor impact on shareholders as it reflects insider activity, but the amount is not significant.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of stock transaction (grant and disposal). |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
BioMarin Pharmaceutical Inc., BMRN, Elizabeth Anderson, Form 4, Stock Transaction, Director, Common Stock, Grant, Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.